China 'No' For Celgene's Paclitaxel A Major Blow To BeiGene

Inspections Report 20% GMP Non-Compliance

 
• By Brian Yang
  
production line
CHINA SUSPENDS CELGENE'S PACLITAXEL DUE TO GMP ISSUES • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business